The Journal of Neuroscience, March 15, 1999, 19(6):2143-2151
Proteolipid Protein Gene Product Can Be Secreted and Exhibit
Biological Activity during Early Development
Masahisa
Yamada1,
Anna
Ivanova1,
Yoshihide
Yamaguchi1,
Marjorie B.
Lees2, and
Kazuhiro
Ikenaka1
1 Laboratory of Neural Information, National Institute
for Physiological Sciences, Okazaki National Research Institutes, Aichi
444-8585, Japan, and 2 Biochemistry Division, E. K. Shriver Center, Waltham, Massachusetts 02254
A gene encoding myelin proteolipid protein (PLP) and its smaller
isoform DM20 is expressed at least 1 week before myelination. Mutations
within the gene cause abnormalities in the development of
premyelinating oligodendrocytes, resulting in hypomyelinating disorders. These findings suggest a premyelinating function of the PLP
gene products. We previously demonstrated that PLP gene expression is
directly associated with secretion of a factor that increases the
number of oligodendrocytes. Here we show that this activity is mediated
by a secreted fragment containing the C-terminal portion of PLP. This
factor increased the bromodeoxyuridine incorporation rate in both
oligodendrocyte and astrocyte lineage cells; a synthetic peptide (PLP
215-232) exhibited a similar activity. Dose-response curves of
PLP and PLP peptide showed maximum activities at a concentration in the
picomolar range, which decreased at higher concentrations. These
observations demonstrate that a secreted PLP gene product exerts
biological activity at a premyelinating stage before the major
induction of the gene.
Key words:
oligodendrocyte development; myelin proteolipid protein; DM20; differentiation factor; myelin; cell culture
Copyright © 1999 Society for Neuroscience 0270-6474/99/1962143-09$05.00/0